Earnings calls / MTARTECH · July 30, 2026

MTAR Technologies Limited Q1 FY27 Earnings Call Summary

Q1 FY27 revenue was ₹360.7 cr (+130.4% YoY), PAT was ₹50.2 cr (+364.5%), and EBITDA margin was 23.54% versus FY27 guidance of 22% ±100 bps. The driver was record orders: closing book ₹5,143 cr plus ₹800 cr on call day, led by nuclear (Kaiga, PFBR) and clean energy, and working capital days fell from 172 in FY26 to 59. Management forecasts FY27 revenue growth of 80% (confident to beat), EBITDA margin 22% ±100 bps, working capital exit ~100 days, and ₹500 cr capex, 70% clean energy. Risks are gross margin down to 45.61% from 47.65% YoY, execution of the ₹5,900+ cr book, and dependence on fuel-cell and export data-center demand.

Revenue
Margin
Demand
Guidance
Tone
Metrics cut 1
  • FY27 working capital days exit target cut to ~100 days (from 150-170 days earlier)

Event Participants

Executives (5)

Gunneswara Rao (CFO), Srinivas Reddy (MD & Promoter), Srileka Jasthi (Head Strategy & IR), Vidhi Vasa (Investor Relations), Orient Capital (IR Partners)

Analysts (9)

Balasubramanian (Arihant Capital), Gaurav Nagori (Avendus Spark), Jenish Karia (Union Mutual Fund), Mohit Kumar (ICICI Securities), Piyush Sevaldasani (Sundaram Alternates), Pritesh Chheda (Lucky Investments), Rohit Natarajan (Axis Max Life), Sumant Kumar (Motilal Oswal Financial Services), Viraj Parekh (Carnelian Asset Management), Vipraw Srivastava (PhillipCapital)

Financials & KPIs

Metric Reported Commentary
Revenue from Operations ₹360.7 crores +130.4% YoY and strong QoQ growth; highest-ever quarterly revenue driven by execution across all verticals
EBITDA ₹85.1 crores +199.7% YoY; EBITDA margin of 23.54% vs 20.11% last quarter, driven by operating leverage and cost monitoring
Profit Before Tax ₹67.4 crores +355% YoY from ₹14.8 crores in Q1 FY2026
Profit After Tax ₹50.2 crores +364.5% YoY from ₹10.8 crores in Q1 FY2026; PAT margin at 13.92% vs 6.9% YoY
Gross Margin 45.61% Down from 47.65% YoY due to revenue mix; management monitoring improvement opportunities
EBITDA Margin 23.54% Within annual guidance of 22% ±100 bps; improved from 20.11% last quarter
Working Capital Days 59 days Dramatic improvement from 172 days in FY2026 (full year); driven by better commercial terms, credit period renegotiation, weekly monitoring
Debt ₹423.6 crores Net debt effectively ₹20-30 crores after adjusting ₹379 crores of investments (as of July end)
Investments ₹379 crores As of July end 2026
Cash Flow from Operations ₹247.69 crores vs ₹191.66 crores last year; improved from working capital initiatives and better terms
ROCE 17.2% Up from 11.4%; management expects to reach 23% next year
Closing Order Book ₹5,143 crores Excluding additional ₹800 crores of orders received on call day (total ~₹5,943 crores)
CapEx (Q1 FY27) ~₹35 crores spent Total ₹500 crores planned for this year and next combined; ₹80 crores capitalized (previously CWIP)

Geographic & Segment Commentary

Civil Nuclear: Received highest-ever order inflow in the segment during the quarter for Kaiga 5 & 6 reactors. Expecting additional refurbishment orders of ₹130-140 crores in the current quarter (total refurbishment pipeline ~₹200+ crores). Company supplied majority of critical assemblies for the PFBR reactor (achieved criticality - a milestone for India's nuclear program). Order book in nuclear stands at ~₹684 crores (excluding expected orders). Execution will commence in H2 FY27 with timeline ranging from 1-3 years. Mahi Banswara (4 reactors via NTPC-NPCIL partnership) represents significant future opportunity with MTAR expecting higher participation than Kaiga.

Clean Energy: Record order inflow during the quarter, strengthening robust order book. Capacity expansion for fuel cells on track - Phase 1 commissioned, Phase 2 to be commissioned by September-October 2026, Phase 3 (multifold expansion) to be completed by March 2027. Entered data center infrastructure solutions segment with first batch of products in progress; initial order ~₹45 crores, with potential requirement of 8x this for annual requirements - all for export markets. Also seeing good traction in hydropower and wind energy. Clean Energy expected to be major revenue driver by end of FY27.

Aerospace & Defense: Expecting significant order inflows - volume orders for actuator assemblies for LCA Mark 1A, wing assemblies, and electromechanical actuators for defense programs (aggregate opportunity ~₹250+ crores). MNC aerospace business showing "phenomenal growth" with demand for qualified products. First articles yielding 10-15x volume orders. Multiple subunits being set up within dedicated aerospace facility. Revenue expected to double in FY27 with significant ramp-up over next 3-4 years.

Oil & Gas: Facility will be operational by October 2026. First articles delivered to customers; first articles for flagship components for another customer in process.

Company-Specific & Strategic Commentary

Order Book Momentum: Closing order book at ₹5,143 crores as of quarter end, with additional ₹800 crores received on call day, taking total to ~₹5,943 crores. Robust ₹5,000+ crores closing order book target for FY27 already exceeded.

Capacity Expansion: ₹500 crores CapEx planned across this year and next (70/30 split - 70% clean energy, 30% other segments). Focus on asset turnover of minimum 4-5x on new investments. Phase 1 fuel cell expansion complete; Phase 2 by September-October 2026; Phase 3 by March 2027.

Working Capital Transformation: Working capital days reduced from 172 days (FY26) to 59 days in Q1 FY27. Achieved through better commercial terms, negotiated credit periods, weekly monitoring, and GST refund targeting of ~₹70 crores annually.

Data Center Entry: New strategic entry into data center infrastructure solutions - all export-oriented. Dedicated facility being set up; first articles in progress with meaningful ramp-up expected over next year.

Manpower & Automation Readiness: Training and automation initiatives underway ahead of capacity coming on stream to ensure operational preparedness for volume ramp-up.

Customer Diversification: Focus on increasing wallet share from existing customers while pursuing new customer qualification in aerospace.

Guidance & Outlook

Metric Guidance / Outlook Commentary
Revenue Growth (FY27) 80% YoY growth Management "pretty confident to do better than the guidance given earlier"; reiterated confidence in achieving target
EBITDA Margin (FY27) 22% ±100 bps Q1 achieved 23.54%; management expects improvement with scale
Working Capital Days (FY27 exit) ~100 days Revised down from earlier guidance of 150-170 days; Q1 achieved 59 days
ROCE 23% next year Current at 17.2%
CapEx ₹500 crores (FY27 + FY28 combined) 70/30 split between clean energy and other segments; funding via internal accruals and debt
Nuclear Execution H2 FY27 ramp-up Execution begins second half of current fiscal, continuing to grow thereafter
Aerospace & Defense Revenue Double in FY27 Largely driven by existing programs and qualified products; significant ramp-up anticipated over next 3-4 years
Closing Order Book (FY27) ₹5,000+ crores Already achieved at ₹5,143 crores; additional orders received on call day

Risks & Constraints

Risk Context
Execution Risk on Ramp-Up Order book growth (₹5,900+ crores) requiring significant capacity expansion across all verticals. Management acknowledges demand depends on "how soon we can implement expansion plan." ₹500 crores CapEx spread across two years with execution timelines requiring operational readiness.
Gross Margin Pressure Gross margins declined from 47.65% to 45.61% YoY due to revenue mix. Management continuously monitoring improvement but mix shift could continue to impact margins.
Nuclear Program Cyclicality Historically cyclical segment now transitioning to more consistent growth trajectory per management. Refurbishment orders (₹200+ crores) provide near-term visibility, but dependency on government program rollout (Mahi Banswara, PFBR) remains.
Customer Concentration - Clean Energy Significant dependence on key fuel cell customer (Bloom) with NDA constraints limiting disclosure. Data center demand subject to U.S. macro conditions - management dismisses "unwanted noise" on delays.
Working Capital Sustainability Reduction from 172 to 59 days achieved via organic measures (better commercial terms). Risk of reversal if customer terms change or project mix shifts to longer-cycle nuclear work. CFO noted inorganic acceleration possible "but not at cost of margins."

Q&A Highlights

Order Book & Execution Timelines

  • Question: Is the ₹800 crore order received today all FY28/FY29 execution with nothing in FY27? (Mohit Kumar, ICICI Securities)

  • Answer: Execution timeline is for next financial year. Speed depends on how quickly expansion plans and ramp-up can be implemented. (Srinivas Reddy)

  • Question: What are execution timelines for Kaiga 5&6 and refurbishment orders? (Mohit Kumar, ICICI Securities)

  • Answer: Refurbishment orders overall ~₹200+ crores; expecting another ₹130-140 crores coming this quarter. Execution within two years for refurbishment; Kaiga 5&6 execution ranges one to three years. Total nuclear orders will reach ~₹800 crores - unprecedented in company history. (Srinivas Reddy; Gunneswara Rao)

Working Capital Improvement

  • Question: How sustainable is the dramatic working capital reduction? What specific initiatives drove this? (Balasubramanian, Arihant Capital)
  • Answer: Negotiated better commercial terms and credit periods with customers. Credit terms improved post-delivery at customer premises. Target of ~100 days for FY27 (down from 150-170 earlier). GST refunds of ~₹70 crores annually improving cash flows. All reductions achieved organically - inorganic options possible but not at cost of margins. (Gunneswara Rao)

Fuel Cell Capacity & Data Center

  • Question: Given strong demand, are you expanding beyond 20,000 hot boxes capacity? What's the new product revenue contributing ~50% of clean energy revenue? (Gaurav Nagori, Avendus Spark)

  • Answer: Phase 3 is a multifold expansion plan ready by March 2027 (commissioning), with ramp-up from April. Can't specify numbers due to NDA. Phase 2 operational by October 2026. New product growth will continue and grow - second half stronger than first half. Products mix includes ball screws with major export contracts for aerospace MNCs. (Srinivas Reddy)

  • Question: What's the current size of data center order? (Vipraw Srivastava, PhillipCapital)

  • Answer: Current order is ₹45 crores to be executed before March 2027. First articles with 2-3 assemblies in progress. Potential requirement of 8 such sets year-on-year. All for export markets. Dedicated facility being set up. (Srinivas Reddy)

Nuclear Opportunity - Mahi Banswara & PFBR

  • Question: What's the TAM from the four Mahi Banswara reactors, and how do you participate? (Viraj Parekh, Carnelian Asset Management)

  • Answer: Participation is through EPC vendors. Tenders already floated for 4 reactors - MTAR's opportunity will be "much higher" than Kaiga 5&6 (which had 3 reactors). Timeline: probably one year process, orders might fit into next financial year. (Srinivas Reddy)

  • Question: What's the opportunity from PFBR program post-criticality? (Viraj Parekh, Carnelian)

  • Answer: MTAR contributed massively to PFBR - exclusively supplied core reactor major assemblies for IGCAR/BHAVINI. Government planning additional reactors; details being shared with company. Direct engagement with government (not EPC). PFBR likely to progress faster given criticality achieved and role in thorium cycle. (Srinivas Reddy)

Revenue Guidance Upgrade Potential

  • Question: Given key client raised guidance 10-15%, can we expect guidance upgrade? (Sumant Kumar, Motilal Oswal)
  • Answer: Management confident in existing guidance and "will definitely do better." Likely clarity by end of next quarter. (Srinivas Reddy)

Funding & Balance Sheet

  • Question: With ₹5,500+ crores order book and ₹500 crores CapEx, how will this be funded? (Jenish Karia, Union Mutual Fund)
  • Answer: Combination of internal accruals and debt. Balance sheet strong - net debt effectively ₹20-30 crores after adjusting investments. Asset turnover target of minimum 4-5x (targeting 6x) on new CapEx. (Gunneswara Rao)

Long-Term Segment Targets

  • Question: What should aerospace and products businesses be in 3-4 years? (Pritesh Chheda, Lucky Investments)
  • Answer: Aerospace could reach ₹600-700 crores; products division could cross ₹1,000 crores. Current order book is short-cycle (2 months to 2 years) - not spread over many years. (Srinivas Reddy)

U.S. Data Center & Interest Costs

  • Question: Any delays in U.S. data center CapEx impacting demand? Also, interest cost bifurcation? (Piyush Sevaldasani, Sundaram Alternates)
  • Answer: "All this is unwanted noise" - things going in the right direction, orders continue to be received. No issues at all. Interest cost breakup not available on call; expectation is costs will reduce quarter-on-quarter. (Srinivas Reddy)

Key Takeaway

MTAR Technologies delivered its highest-ever quarterly revenue of ₹360.7 crores in Q1 FY27, up 130.4% YoY, with EBITDA margins of 23.5% and PAT of ₹50.2 crores (+364.5% YoY). The company's order book reached ₹5,143 crores at quarter end, augmented by an additional ₹800 crores received on the call day (total ~₹5,943 crores), with management confident of exceeding the 80% revenue growth guidance for FY27. Strategic momentum spans civil nuclear (₹684+ crores orders, PFBR contribution, Mahi Banswara opportunity), clean energy (record inflows, multifold Phase 3 fuel cell expansion by March 2027, new data center infrastructure entry with ₹45 crore initial order and 8x annual potential), and aerospace & defense (revenue expected to double in FY27). Working capital transformation from 172 to 59 days and effectively debt-free balance sheet position the company for its ₹500 crore CapEx program (70% clean energy). Key watch points include execution of the massive order book ramp-up, gross margin sustainability amid mix shifts, and continued order inflows to sustain the growth trajectory beyond FY27.

What you get with InvestorStack

Institutional-grade research, built for individual investors.

  • Research Reports for 1,800+ companies
  • Detailed valuation models
  • Growth triggers, Risks, KPIs, Read between the lines
  • Scans, One pagers, Industry research reports
Try for free